Loading
IARC estimates 16,582 new cancer cases and 9,792 cancer deaths in Zambia in 2024; the commonest new cancers are cervix uteri, breast and Kaposi sarcoma. This page is assembled automatically from OnCo's data: 2 institutions and 1 person, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 4,730 | 74.8 | Cervical cancer |
| Breast | 1,555 | 24.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Kaposi sarcoma | 1,378 | 8.7 | Kaposi sarcoma |
| Prostate | 1,341 | 50.3 | Prostate cancer |
| Colorectum | 729 | 7.5 | Colorectal cancer |
| Oesophagus | 564 | 6.0 | Oesophageal cancer |
| Vulva | 432 | 6.0 | Vulvar cancer |
| Liver and intrahepatic bile ducts | 378 | 3.9 | Hepatocellular carcinoma |
| Non-Hodgkin lymphoma | 358 | 2.7 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Stomach | 356 | 4.3 | Gastric & gastro-oesophageal junction cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 2,769 | 45.4 | Cervical cancer |
| Prostate | 826 | 31.2 | Prostate cancer |
| Breast | 730 | 12.3 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Kaposi sarcoma | 562 | 3.7 | Kaposi sarcoma |
| Oesophagus | 495 | 5.5 | Oesophageal cancer |
| Colorectum | 410 | 4.6 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 337 | 3.6 | Hepatocellular carcinoma |
| Stomach | 279 | 3.6 | Gastric & gastro-oesophageal junction cancer |
| Leukaemia | 214 | 1.4 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Trachea, bronchus and lung | 197 | 2.6 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
No trial record in OnCo lists a site in Zambia. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
People whose main affiliation in OnCo is an institution or company in Zambia.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Zambia is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Zambia is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.